Home › Funds › ACUTA CAPITAL PARTNERS, LLC › CTNM
ACUTA CAPITAL PARTNERS, LLC position in CTNM
CONTINEUM THERAPEUTICS INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 89,826 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.95% of its reported portfolio and ranking #26 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed CTNM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's CTNM position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in CTNM in Q2 2026 at 63,095 shares (US$1.0M). The position peaked in Q3 2026 at 89,826 shares, worth US$1.2M. Across 2 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 89,826 shares valued at US$1.2M — an increase of 26,731 shares quarter over quarter.. Notable position changes include a 42% increase in Q3 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 63.09K | $1.03M | New |
| Q3 2026 | 89.83K | $1.21M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CTNM and 13F data
CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$46.6M), JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTNM
- MONTANOVA CAPITAL, LLC 2.84M sh · $46.57M · Q2 2026
- JOHNSON & JOHNSON 1.98M sh · $26.56M · Q3 2026
- Trails Edge Capital Partners, LP 1.69M sh · $22.73M · Q3 2026
- Versant Venture Management, LLC 1.29M sh · $17.35M · Q3 2026
- GREAT POINT PARTNERS LLC 921.48K sh · $15.10M · Q2 2026
- Ikarian Capital, LLC 807.87K sh · $13.24M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 669.34K sh · $10.97M · Q2 2026
- SECTORAL ASSET MANAGEMENT INC 689.59K sh · $9.25M · Q3 2026
- Red Tree Management, LLC 638.16K sh · $8.56M · Q3 2026
- Boxer Capital Management, LLC 494.00K sh · $8.10M · Q2 2026
- Squadron Capital Management LLC 260.00K sh · $4.26M · Q2 2026
- HighVista Strategies LLC 217.79K sh · $2.92M · Q3 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held CTNM?
ACUTA CAPITAL PARTNERS, LLC has disclosed CTNM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in CTNM?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 89.83K shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $1.21M, representing 0.95% of its reported portfolio and ranking #26.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling CTNM?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC increased its position in CTNM. The position peaked in Q3 2026 at 89.83K shares.
Which other funds hold CTNM?
Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.